The Cooper Companies Inc (BSP:C1OO34)
R$ 60.54 0 (0%) Market Cap: 120.57 Bil Enterprise Value: 135.18 Bil PE Ratio: 58.61 PB Ratio: 2.64 GF Score: 81/100

Cooper Companies Inc at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum (Virtual) Transcript

Mar 21, 2023 / 05:30PM GMT
Release Date Price: R$44.91
Matthew Ian Mishan
KeyBanc Capital Markets Inc., Research Division - VP & Senior Equity Research Analyst

Good afternoon. I'd like to welcome everyone again to the KeyBank Life Sciences and MedTech Investor Forum. My name is Matt Mishan, I am senior MedTech analyst. I'm pleased to be joined by CooperCompanies, who is represented today by CFO and Treasurer, Brian Andrews; and EVP and COO, Dan McBride. Thank you guys for joining us. I'm going to start us off, but this will be 100% Q&A and questions can be submitted directly to me by typing into the box below the video screen and then I can relay from there.

Questions & Answers

Matthew Ian Mishan;Brian G. Andrews
KeyBanc Capital Markets Inc., Research Division - VP & Senior Equity Research Analyst;Cooper

But I'll start off. I guess, Brian, I'm asking this question to you. It's basically as you're in San Francisco, are you talking to other CFOs about the Silicon Valley Bank issues? How do you think about direct versus tail risk at this point from that?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot